(a) IL-17
(b) IL-23
(c) IL-6
(d) Ferritin
(e) IL-10
(f) IL-1RA
(g) TNF-α
Figure 4: Median percent change in select biomarkers with placebo, apremilast 20 mg BID, and apremilast 30 mg BID over Weeks 0 to 40.